IP Library › Patent Application 13293935
Patent Application
App. No. 13/293,935

NMDAR BIOMARKERS FOR DIAGNOSING AND TREATING CEREBRAL ISCHEMIA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/293,935
Abstract

The present invention relates to methods for detecting various subunits and isoforms of NMDA receptors to help diagnose and differentiate (1) the anatomical location of NMDA receptor over-expression, and (2) ischemic conditions in the central and peripheral nervous systems.

Claims (8)

1 - 42 . (canceled)

43 ) An isolated peptide comprising SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO:4, or an analog thereof.

44 ) The peptide of claim 43 linked to a diagnostic substrate or indicator reagent.

45 ) The peptide of claim 43 comprising SEQ ID NO:1.

46 ) The peptide of claim 43 comprising SEQ ID NO:2.

47 ) The peptide of claim 43 comprising SEQ ID NO:3.

48 ) The peptide of claim 43 comprising SEQ ID NO:4.

49 ) An isolated nucleic acid that encodes for a peptide comprising SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3 or SEQ ID NO:4, or an analog thereof.